Woman Seemingly Cured of HIV After Umbilical Cord Transplant

Umbilical cord blood may be a good alternative to bone marrow transplants for treating HIV in patients with HIV and cancer.

Written byNatalia Mesa, PhD
| 3 min read
T cell depicted with other blurred T cells behind it
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A woman in the New York City area appears to be the third person and the first woman ever to be cured of an HIV infection following a new stem cell transplant treatment involving umbilical cord blood. She has shown no detectable signs of the virus since stopping antiretroviral treatment in October 2020.

Her doctors presented the case on Tuesday (February 15) at the Conference on Retroviruses and Opportunistic Infections in Denver, but the findings have not yet been published.

“Everything is looking very promising,” Marshall Glesby, the chief of the division of infectious diseases at Weill Cornell Medicine and New York-Presbyterian, who treated the woman, tells The Wall Street Journal.

According to The New York Times, the woman was diagnosed with HIV in 2013. In March 2017, she was diagnosed with acute myeloid leukemia, which made her a candidate for a stem cell transplant, according to the Journal.

Later ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot

    As she was completing her graduate thesis on the neuroscience of vision, Natalia found that she loved to talk to other people about how science impacts them. This passion led Natalia to take up writing and science communication, and she has contributed to outlets including Scientific American and the Broad Institute. Natalia completed her PhD in neuroscience at the University of Washington and graduated from Cornell University with a bachelor’s degree in biological sciences. She was previously an intern at The Scientist, and currently freelances from her home in Seattle. 

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery